60 http://www.prwebpodcast.com A Top 30 Stream of SALUGEN, INC. Press Releases (in OGG format) via PRWeb podEditor@emediawire.com (PRWeb) podMaster@emediawire.com Sat, 04 Jul 2009 21:27:52 -0700 SALUGEN, INC. http://www.prweb.com/prwebrss.gif 130 49 http://prwebpodcast.com Copyright PRWeb International, Inc. en-us http://blogs.law.harvard.edu/tech/rss A Top 30 Stream of SALUGEN, INC. Press Releases (in OGG format) via PRWeb A Top 30 Stream of SALUGEN, INC. Press Releases (in OGG format) via PRWeb podEditor@emediawire.com PR Web PRWeb no http://www.prweb.com/releases/2006/8/prweb420499.htm http://www.prweb.com/releases/2006/8/prweb420499.htm Makers of GenoTrim respond to a recent survey of 11,000 Americans suggesting that obese persons eat just as healthy and exercise as much as normal weight persons. [PRWeb Aug 7, 2006] http://www.prweb.com/releases/2006/8/prweb420499.htm Fri, 18 Aug 2006 14:27:41 -0700 podcrew@extrahoop.com Florina Crews Salugen Award-Winning Research Begins to Explain Why Obese People Eat Healthy and Exercise Regularly without Losing Weight 00:15:00 no http://www.prweb.com/releases/2006/7/prweb412757.htm http://www.prweb.com/releases/2006/7/prweb412757.htm Salugen researchers present data at the Annual Meeting of the National Nutritional Foods Association suggesting that consumers tested with the "Sweet Tooth Gene" (Dopamine D2 Receptor Gene) can benefit for DNA-Customized GenoTrim. [PRWeb Jul 19, 2006] http://www.prweb.com/releases/2006/7/prweb412757.htm Wed, 19 Jul 2006 16:45:06 -0700 podcrew@extrahoop.com www.genotrim.com). In a study of 901 subjects entitled, “Dopamine D2 receptor gene polymorphisms are significantly associated with percentage body fat and obesity in the D.I.E.T. Study: a functional basis for the nutrigenomic response of chromium picolinate (CrP) in producing body composition effects,” Salugen Chief Scientific Officer and Adjunct Professor at Wake Forest University School of Medicine, Dr. Kenneth Blum, presented early findings suggesting the need to genotype obese subjects for the “Sweet Tooth Gene” (Dopamine De Receptor Gene) prior to chromium picolinate nutritional supplementation as a treatment modality resulting in weight loss. “Over the past thirty years, we have conducted studies providing evidence correlating dopaminergic genes and obesity, body mass index (BMI), body type, overeating, carbohydrate binging, and low dopamine D2 receptor (D2R) density,” says Dr. Blum. “But there are few studies involving the dopamine d2 receptor gene (DRD2) variants and percentage body fat.” Salugen has a DNA-customized nutritional solution for weight management, GenoTrim, which analyzes a panel of genes and based upon those genes, provides a nutritional supplement targeted to the individual. One of those genes in the GenoTrim panel is the “Sweet Tooth Gene” (Dopamine D2 Receptor Gene A1 and A2 allele). Dr. Blum goes to explain, “The effectiveness of chromium picolinate (CrP) in altering body composition has been controversial. Evidence from this multi-centered study may provide a functional basis linking dopaminergic gene polymorphisms first to percent body fat and obesity and secondarily to the nutrigenomic response of CrP in producing body composition effects.” GenoTrim includes chromium picolinate (CrP) that is included and dosed based an individual’s genetic profile. In this multi-centered study, a total of 901 subjects were genotyped for the “Sweet Tooth Gene” (A1 and A2 allele). A total of 257 subjects were assessed for weight, BMI (kg/m2) and percent body fat using dual energy X-ray absorptiometry (DEXA). The remaining 644 subjects were part of the D.I.E.T. study and were assessed using a questionnaire. In the first population, the “Sweet Tooth Gene” (A1 allele) was present in 67% of the obese subjects compared to 3.3 % of the well-screened controls A and 33.3 % for controls B. These differences were significant: Controls A vs. Obese subjects: (r2 = 39.6, df =1, p value less than 0.0001), and Controls B vs. Obese subjects (r2 = 25.9, df = 1, p value less than 0.0001). With regard to the effects of CrP, the measurable change in fat weight (p value less than 0.041), body weight (p value less than 0.017), percent change in weight (p value less than 0.044), and body weight change in kilograms (p value less than 0.012) were all significant for carriers of the “Sweet Tooth Gene” (A2 allele). No significance was found for... To read the press release in full goto http://www.prweb.com/releases/2006/7/prweb412757.htm]]> Florina Crews Early Results from the D.I.E.T. Study (Phase 1) Suggest that DNA-Customized GenoTrim Ingredient May Lower Fat and Body Weight www.genotrim.com). In a study of 901 subjects entitled, “Dopamine D2 receptor gene polymorphisms are significantly associated with percentage body fat and obesity in the D.I.E.T. Study: a functional basis for the nutrigenomic response of chromium picolinate (CrP) in producing body composition effects,” Salugen Chief Scientific Officer and Adjunct Professor at Wake Forest University School of Medicine, Dr. Kenneth Blum, presented early findings suggesting the need to genotype obese subjects for the “Sweet Tooth Gene” (Dopamine De Receptor Gene) prior to chromium picolinate nutritional supplementation as a treatment modality resulting in weight loss. “Over the past thirty years, we have conducted studies providing evidence correlating dopaminergic genes and obesity, body mass index (BMI), body type, overeating, carbohydrate binging, and low dopamine D2 receptor (D2R) density,” says Dr. Blum. “But there are few studies involving the dopamine d2 receptor gene (DRD2) variants and percentage body fat.” Salugen has a DNA-customized nutritional solution for weight management, GenoTrim, which analyzes a panel of genes and based upon those genes, provides a nutritional supplement targeted to the individual. One of those genes in the GenoTrim panel is the “Sweet Tooth Gene” (Dopamine D2 Receptor Gene A1 and A2 allele). Dr. Blum goes to explain, “The effectiveness of chromium picolinate (CrP) in altering body composition has been controversial. Evidence from this multi-centered study may provide a functional basis linking dopaminergic gene polymorphisms first to percent body fat and obesity and secondarily to the nutrigenomic response of CrP in producing body composition effects.” GenoTrim includes chromium picolinate (CrP) that is included and dosed based an individual’s genetic profile. In this multi-centered study, a total of 901 subjects were genotyped for the “Sweet Tooth Gene” (A1 and A2 allele). A total of 257 subjects were assessed for weight, BMI (kg/m2) and percent body fat using dual energy X-ray absorptiometry (DEXA). The remaining 644 subjects were part of the D.I.E.T. study and were assessed using a questionnaire. In the first population, the “Sweet Tooth Gene” (A1 allele) was present in 67% of the obese subjects compared to 3.3 % of the well-screened controls A and 33.3 % for controls B. These differences were significant: Controls A vs. Obese subjects: (r2 = 39.6, df =1, p value less than 0.0001), and Controls B vs. Obese subjects (r2 = 25.9, df = 1, p value less than 0.0001). With regard to the effects of CrP, the measurable change in fat weight (p value less than 0.041), body weight (p value less than 0.017), percent change in weight (p value less than 0.044), and body weight change in kilograms (p value less than 0.012) were all significant for carriers of the “Sweet Tooth Gene” (A2 allele). No significance was found for... To read the press release in full goto http://www.prweb.com/releases/2006/7/prweb412757.htm]]> 00:15:00 no http://www.prweb.com/releases/2006/7/prweb408873.htm http://www.prweb.com/releases/2006/7/prweb408873.htm Experienced Executives and Researchers join to deliver on the promise of Personalized Medicine, first focusing on complementary and alternative therapies [PRWeb Jul 10, 2006] http://www.prweb.com/releases/2006/7/prweb408873.htm Tue, 11 Jul 2006 12:46:14 -0700 podcrew@extrahoop.com Florina Crews Salugen Announces the End of "One-Size-Fits-All" Nutrition by Setting the Bar for a New Approach to Wellness 00:15:00 no